The present invention a method of treating anxiety by administering compounds that are active on the GABA.sub.B receptor, having formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined in the specification and claims.

 
Web www.patentalert.com

< Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses

> Tyrosine kinase inhibitors

> Maleiimide anti-tumor phosphatase inhibitors
~ 00503